CS logo
small CS logo
Advent Clinical Research Centers, Inc.

Pinellas Park, Florida, United States
Endocrinologist in Pinellas Park, Florida
4820 Park Blvd N, Pinellas Park, FL 33781

About Advent Clinical Research Centers, Inc.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Advent Clinical Research Centers, Inc.


During the past decade, Advent Clinical Research Centers, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 14 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer
2009-05-01
2010-05-01
Completed
15
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
2011-07-06
2021-07-30
Completed
1,401
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study
2012-08-24
2022-05-31
Completed
717
A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)
2012-12-03
2017-05-31
Terminated
182

Rows per page:

1–5 of 5

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Advent Clinical Research Centers, Inc." #1 sponsor was "Pfizer" with 10 trials, followed by "Amgen" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Cephalon" with 1 trials sponsored and "Endo Pharmaceuticals" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Advent Clinical Research Centers, Inc." #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Advent Clinical Research Centers, Inc.


According to Clinical.Site data, the most researched conditions in "Advent Clinical Research Centers, Inc." are "Osteoarthritis" (7 trials), "Arthritis" (3 trials), "Low Back Pain" (3 trials), "Acute Coronary Syndrome" (1 trials) and "Adhesive Capsulitis" (1 trials). Many other conditions were trialed in "Advent Clinical Research Centers, Inc." in a lesser frequency.

Clinical Trials Intervention Types at Advent Clinical Research Centers, Inc.


Most popular intervention types in "Advent Clinical Research Centers, Inc." are "Drug" (12 trials), "Biological" (11 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "tanezumab" (5 trials), "AA4500 0.29 mg/1 mL" (1 trials), "AA4500 0.58 mg/0.5 mL" (1 trials) and "AA4500 0.58 mg/1 mL" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Advent Clinical Research Centers, Inc.


The vast majority of trials in "Advent Clinical Research Centers, Inc." are 19 trials for "All" genders.

Clinical Trials Status at Advent Clinical Research Centers, Inc.


Currently, there are NaN active trials in "Advent Clinical Research Centers, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Advent Clinical Research Centers, Inc., undefined suspended trials, and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Advent Clinical Research Centers, Inc., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status